Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 29: 427-433, 1983;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosseneu, M.
Right arrow Articles by Cooper, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosseneu, M.
Right arrow Articles by Cooper, G. R.

Clinical Chemistry, Vol 29, 427-433, Copyright © 1983 by American Association for Clinical Chemistry

Some considerations of methodology and standardization of apolipoprotein B immunoassays

M Rosseneu, R Vercaemst, KK Steinberg and GR Cooper

Apolipoprotein B, the major protein component of very-low-density (VLDL) and low-density (LDL) lipoproteins in serum, is being widely measured in serum, to help assess risk of cardiovascular disease. Standardization has proven difficult because of the physical and immunochemical heterogeneity of LDL and VLDL, the masking of antigenic determinants of LDL and VLDL, the insolubility of apolipoprotein B, the instability of lipoprotein reference materials, and the multiplicity of analytical methods. Here we have examined the literature and collected current information from lipoprotein scientists to determine the problems--and the ways investigators have attempted to solve them--in preparation, storage, and use of standards and anti-apolipoprotein B sera, analytical procedures and reagents, and the nature of apolipoprotein B in serum. Standardization appears possible with development of stable reference materials that are applicable to the various analytical methods, controlled immunochemical reaction conditions, and establishment of a selected interim reference method for use as a point of reference.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
Z. Jiang, S. Sun, A. Liang, W. Huang, and A. Qin
Gold-labeled nanoparticle-based immunoresonance scattering spectral assay for trace apolipoprotein AI and apolipoprotein B.
Clin. Chem., July 1, 2006; 52(7): 1389 - 1394.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. J. Chaves, J. T. Real, A. B. Garcia-Garcia, M. Civera, M. E. Armengod, J. F. Ascaso, and R. Carmena
Genetic Diagnosis of Familial Hypercholesterolemia in a South European Outbreed Population: Influence of Low-Density Lipoprotein (LDL) Receptor Gene Mutations on Treatment Response to Simvastatin in Total, LDL, and High-Density Lipoprotein Cholesterol
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4926 - 4932.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J.T Real, F.J Chaves, I Martinez-Uso, A.B Garcia-Garcia, J.F Ascaso, and R Carmena
Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia
Eur. Heart J., March 2, 2001; 22(6): 465 - 471.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. Carmena-Ramon, J. F. Ascaso, J. T. Real, J. M. Ordovas, and R. Carmena
Genetic Variation at the ApoA-IV Gene Locus and Response to Diet in Familial Hypercholesterolemia
Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1266 - 1274.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Association for Clinical Chemistry.